Cargando…

Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen Gene

We have developed transgenic mice that inherit albumin promoter‐regulated simian virus 40 (SV40) large T antigen gene, expressed specifically in hepatocytes. These mice all develop multifocal hepatocellular carcinomas at around 5 months and die of liver insufficiency by 7 months. Sequential morpholo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hino, Okio, Kitagawa, Tomoyuki, Nomura, Kimie, Ohtake, Keiko, Cui, Lixin, Furuta, Yasuhide, Shinichi, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 1991
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918330/
https://www.ncbi.nlm.nih.gov/pubmed/1684356
http://dx.doi.org/10.1111/j.1349-7006.1991.tb01785.x
_version_ 1783317396908408832
author Hino, Okio
Kitagawa, Tomoyuki
Nomura, Kimie
Ohtake, Keiko
Cui, Lixin
Furuta, Yasuhide
Shinichi, Shinichi
author_facet Hino, Okio
Kitagawa, Tomoyuki
Nomura, Kimie
Ohtake, Keiko
Cui, Lixin
Furuta, Yasuhide
Shinichi, Shinichi
author_sort Hino, Okio
collection PubMed
description We have developed transgenic mice that inherit albumin promoter‐regulated simian virus 40 (SV40) large T antigen gene, expressed specifically in hepatocytes. These mice all develop multifocal hepatocellular carcinomas at around 5 months and die of liver insufficiency by 7 months. Sequential morphological observation of hepatocarcinogenesis revealed 5 distinct stages: (I) newborn to 2 weeks of age, neither recognizable histological changes nor cellular replication in spite of T antigen expression; (II) between 3 and 7 weeks, diffuse cytomegalic change of hepatocytes with numerous abnormal mitoses, usually resulting in cell death; (III) from 7 weeks onwards, quasi‐regenerative small hepatocyte foci with a decreased tendency for cytomegaly in spite of T antigen expression, rapidly replacing the hepatic tissue; (IV) 11 weeks of age and thereafter, neoplastic foci and nodules with enzymatic alteration; (V) 20 weeks of age and thereafter, gross hepatocellular carcinomas with occasional pulmonary metastases. Considerable variation existed both in morphological and enzymatic features and T antigen expression among neoplastic lesions, including carcinomas. Thus, these transgenic mice clearly show a multistep process in hepatocarcinogenesis with remarkable synchrony and provide a promising model for analyzing the essential events of carcinogenesis at different stages.
format Online
Article
Text
id pubmed-5918330
institution National Center for Biotechnology Information
language English
publishDate 1991
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-59183302018-05-11 Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen Gene Hino, Okio Kitagawa, Tomoyuki Nomura, Kimie Ohtake, Keiko Cui, Lixin Furuta, Yasuhide Shinichi, Shinichi Jpn J Cancer Res Article We have developed transgenic mice that inherit albumin promoter‐regulated simian virus 40 (SV40) large T antigen gene, expressed specifically in hepatocytes. These mice all develop multifocal hepatocellular carcinomas at around 5 months and die of liver insufficiency by 7 months. Sequential morphological observation of hepatocarcinogenesis revealed 5 distinct stages: (I) newborn to 2 weeks of age, neither recognizable histological changes nor cellular replication in spite of T antigen expression; (II) between 3 and 7 weeks, diffuse cytomegalic change of hepatocytes with numerous abnormal mitoses, usually resulting in cell death; (III) from 7 weeks onwards, quasi‐regenerative small hepatocyte foci with a decreased tendency for cytomegaly in spite of T antigen expression, rapidly replacing the hepatic tissue; (IV) 11 weeks of age and thereafter, neoplastic foci and nodules with enzymatic alteration; (V) 20 weeks of age and thereafter, gross hepatocellular carcinomas with occasional pulmonary metastases. Considerable variation existed both in morphological and enzymatic features and T antigen expression among neoplastic lesions, including carcinomas. Thus, these transgenic mice clearly show a multistep process in hepatocarcinogenesis with remarkable synchrony and provide a promising model for analyzing the essential events of carcinogenesis at different stages. Blackwell Publishing Ltd 1991-11 /pmc/articles/PMC5918330/ /pubmed/1684356 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01785.x Text en
spellingShingle Article
Hino, Okio
Kitagawa, Tomoyuki
Nomura, Kimie
Ohtake, Keiko
Cui, Lixin
Furuta, Yasuhide
Shinichi, Shinichi
Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen Gene
title Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen Gene
title_full Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen Gene
title_fullStr Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen Gene
title_full_unstemmed Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen Gene
title_short Hepatocarcinogenesis in Transgenic Mice Carrying Albumin‐promoted SV40 T Antigen Gene
title_sort hepatocarcinogenesis in transgenic mice carrying albumin‐promoted sv40 t antigen gene
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918330/
https://www.ncbi.nlm.nih.gov/pubmed/1684356
http://dx.doi.org/10.1111/j.1349-7006.1991.tb01785.x
work_keys_str_mv AT hinookio hepatocarcinogenesisintransgenicmicecarryingalbuminpromotedsv40tantigengene
AT kitagawatomoyuki hepatocarcinogenesisintransgenicmicecarryingalbuminpromotedsv40tantigengene
AT nomurakimie hepatocarcinogenesisintransgenicmicecarryingalbuminpromotedsv40tantigengene
AT ohtakekeiko hepatocarcinogenesisintransgenicmicecarryingalbuminpromotedsv40tantigengene
AT cuilixin hepatocarcinogenesisintransgenicmicecarryingalbuminpromotedsv40tantigengene
AT furutayasuhide hepatocarcinogenesisintransgenicmicecarryingalbuminpromotedsv40tantigengene
AT shinichishinichi hepatocarcinogenesisintransgenicmicecarryingalbuminpromotedsv40tantigengene